您的位置: 首页 > 农业专利 > 详情页

DÉRIVÉ DE PIPÉRAZINE
专利权人:
Astellas Pharma Inc.
发明人:
SUGANE, Takashi,ASAI, Norio,MORITOMO, Hiroyuki,YAMASHITA, Daisuke,HOSOGAI, Naomi
申请号:
EP17830975
公开号:
EP3489231A4
申请日:
2017.07.18
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
[Problem] To provide a compound useful as an MCreceptor agonist. [Solution] The present inventors have made studies on MCreceptor agonists. As a result, it is confirmed that a piperazine derivative has an MCreceptor agonist activity, which leads to the accomplishment of the present invention. The piperazine derivative according to the present invention has an MCreceptor agonist activity, and therefore can be used as a prophylactic or therapeutic agent for disturbance of urination in bladder and urinary tract diseases, particularly underactive bladder, hypotonic bladder, acontractile bladder, detrusor underactivity, neurogenic bladder, urethral relaxation failure, detrusor-sphincter dyssynergia and prostatic hyperplasia.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充